Tag Archives: NASDAQ:AVRO

A Hat Trick Of Cell And Gene Therapy IPOs: Avro, Magenta, and Unum
June 28, 2018

Last week, AvroBio and Magenta Therapeutics priced their IPOs on the same night. Less than three months earlier, Unum Therapeutics priced its IPO. All three biotech companies are emerging leaders in the cell and gene therapy space, broadly defined. They

Leave a comment